Peter Miller to Female
This is a "connection" page, showing publications Peter Miller has written about Female.
Connection Strength
0.305
-
Schertz AR, Sarma AK, Datar S, Miller PJ. Reversible cerebral vasoconstriction syndrome (RCVS) caused by over-the-counter calcium supplement ingestion. BMJ Case Rep. 2021 Jan 28; 14(1).
Score: 0.057
-
Maslonka MA, Schertz AR, Markowski LM, Miller PJ. Sedation challenges in patients with E-cigarette, or vaping, product use-associated lung injury (EVALI). BMJ Case Rep. 2020 Sep 02; 13(9).
Score: 0.056
-
Bonnecaze AK, Wilson MW, Dharod A, Fletcher A, Miller PJ. Acute kidney injury is common with intravenous abuse of extended-release oral oxymorphone and delayed renal recovery rates are associated with increased KDIGO staging. Nephrology (Carlton). 2018 Oct; 23(10):921-926.
Score: 0.049
-
Wilson MW, Bonnecaze AK, Dharod A, Miller PJ. Analysis of Intensive Care Unit Admission and Sequelae in Patients Intravenously Abusing Extended-Release Oral Oxymorphone. South Med J. 2017 03; 110(3):217-222.
Score: 0.044
-
Bonnecaze AK, Stephens SE, Miller PJ. Non-lethal Clostridium sordellii bacteraemia in an immunocompromised patient with pleomorphic sarcoma. BMJ Case Rep. 2016 Aug 03; 2016.
Score: 0.042
-
Miller PJ, Farland AM, Knovich MA, Batt KM, Owen J. Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange. Am J Hematol. 2014 Jul; 89(7):695-7.
Score: 0.036
-
Kuhlman P, Miller P, Farland A, Owen J, Batt K. Correlating S100B with disease course in a case of new onset, acquired thrombotic thrombocytopenic purpura (TTP): Could this be a new predictive biomarker in TTP? J Clin Apher. 2018 Aug; 33(4):541-545.
Score: 0.012
-
Hunt R, Yalamanoglu A, Tumlin J, Schiller T, Baek JH, Wu A, Fogo AB, Yang H, Wong E, Miller P, Buehler PW, Kimchi-Sarfaty C. A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER. Blood. 2017 02 16; 129(7):896-905.
Score: 0.011